Cefprozil Powder, For Suspension
Product Images NDC 16714-397

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cefprozil (NDC 16714-397). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (125 mg/5 mL (50 mL Bottle))

Package Label-principal Display Panel (125 mg/5 mL (50 mL Bottle))
This is a description of Cefprozil for Oral Suspension, USP. It is an antibiotic consisting of 125 mg/5mL of cefprozil. The suspension is prepared by adding a total of 35 mL water in two portions and shaking well after each addition, which provides 50 mL of the suspension. The suspension should be stored in a refrigerator and should be discarded after 14 days. The package insert contains information about the dosage and administration of the drug. The product has phenylalanine, and it should be kept out of the reach of children. It should be stored at 20°C to 25°C (68°F to 77°F). The drug is manufactured by Aurobindo Pharma Limited in India and distributed by Northstar Rx LLC in Memphis, TN.*
FDA Label Image

Package Label-principal Display Panel (250 mg/5 mL (50 mL Bottle))

Package Label-principal Display Panel (250 mg/5 mL (50 mL Bottle))
NDC 16714-397-01 is a Cefprozil for Oral Suspension, USP containing 250 mg/5mL in a 50mL bottle when reconstituted. This needs to be prepared at the time of dispensing. It contains cefprozil USP, equivalent to 250 mg anhydrous cefprozil. The usual dosage is mentioned on the package insert. The product is manufactured in India and packaged in Memphis, TN. It is essential to keep the drug out of the reach of children and store the content in the refrigerator. The suspension, when constituted, should be used within 14 days. The overprinting zone is given and cannot be printed.*
FDA Label Image

Chemical Structure (Cefprozil Str)

Chemical Structure (Cefprozil Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.